ArticleProceedings of the National Academy of Sciences of the United States of America2015

Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.

Xi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.